Amprius Technologies (NYSE: AMPX) insider plans more stock sales
Rhea-AI Filing Summary
Amprius Technologies, Inc. (symbol AMPX) is named as the issuer in a notice filed by insider Thomas M. Stepien to sell company common stock under Rule 144. The planned transaction involves 8,000 shares of common stock held at Morgan Stanley Smith Barney LLC, relating to restricted stock that vests on August 20, 2026 under a registered plan, with the issuer listed as Amprius and the consideration described as services rendered.
Over the prior three months, Thomas M. Stepien reported additional sales of Amprius common stock: 23,529 shares for $243,312.64 on August 20, 2026; 2,000 shares for $41,940.00 on June 4, 2026; and 4,375 shares for $75,221.56 on May 27, 2026.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 8,000 shares of common stock
Recent sale on August 20, 2026: 23,529 shares for $243,312.64
Sale on June 4, 2026: 2,000 shares for $41,940.00
+2 more
5 metrics
Planned shares to be sold
8,000 shares of common stock
Planned Rule 144 sale related to restricted stock vesting on August 20, 2026
Recent sale on August 20, 2026
23,529 shares for $243,312.64
Sale of Amprius common stock by Thomas M. Stepien
Sale on June 4, 2026
2,000 shares for $41,940.00
Sale of Amprius common stock by Thomas M. Stepien
Sale on May 27, 2026
4,375 shares for $75,221.56
Sale of Amprius common stock by Thomas M. Stepien
Vesting date of restricted stock
August 20, 2026
Restricted stock vesting under a registered plan related to the 8,000 shares
Key Terms
Rule 144, Restricted Stock Vesting, Registered Plan
3 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Vesting financial
"Restricted Stock Vesting Under a Registered Plan"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
Registered Plan financial
"Restricted Stock Vesting Under a Registered Plan"
A registered plan is a savings or investment account that a government recognizes for special tax treatment and rules, such as limits on how much you can put in and conditions for withdrawals. For investors it matters because those rules change how much of your gains are taxed, how quickly your money can be accessed and what strategies make sense — like a labeled jar that gives tax breaks but comes with rules about when and how you can take the money out.
FAQ
What insider transaction does this Form 144 report for AMPX?
The notice reports that Thomas M. Stepien plans to sell 8,000 shares of Amprius Technologies, Inc. common stock under Rule 144, related to restricted stock vesting on August 20, 2026 under a registered plan, with consideration described as services rendered.
What AMPX insider sales were made by Thomas M. Stepien in the past three months?
Over the past three months, Thomas M. Stepien reported selling 23,529 shares for $243,312.64 on August 20, 2026; 2,000 shares for $41,940.00 on June 4, 2026; and 4,375 shares for $75,221.56 on May 27, 2026.
What type of AMPX securities are involved in this Form 144 filing?
The filing concerns common stock of Amprius Technologies, Inc. The 8,000 shares to be sold arise from restricted stock vesting on August 20, 2026 under a registered plan, with consideration identified as services rendered to the issuer.
What is the aggregate value associated with the recent AMPX insider sales reported?
Recent reported sales by Thomas M. Stepien include $243,312.64 on 23,529 shares, $41,940.00 on 2,000 shares, and $75,221.56 on 4,375 shares of Amprius Technologies, Inc. common stock over the three-month period covered.
AI-generated analysis. How Rhea-AI works. Not financial advice.